Article
TREX1 as a Novel Immunotherapeutic Target
1 Apr 2021
Abstract excerpt
Mutations in the TREX1 3' → 5' exonuclease are associated with a spectrum of autoimmune disease phenotypes in humans and mice. Failure to degrade DNA activates the cGAS-STING DNA-sensing pathway signaling a type-I interferon (IFN) response that ultimately drives immune system activation. TREX1 and the cGAS-STING DNA-sensing pathway have also been implicated in the tumor microenvironment, where TREX1 is proposed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
